Clear Cell Carcinoma clinical trials at UCSF
1 research study open to eligible people
Clear cell carcinoma is a type of cancer that can occur in different organs. UCSF is studying a new treatment called Vudalimab for people with advanced gynecologic and genitourinary cancers. This research is part of a Phase 2 clinical trial to find better ways to treat these cancers.
Showing trials for
XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies
open to eligible people ages 18 years and up
This is a Phase 2, multicenter, two-stage, open-label, parallel-group study designed to evaluate the efficacy and safety of vudalimab (XmAb20717) in patients with selected advanced gynecologic and genitourinary malignancies.
San Francisco, California and other locations
Last updated: